Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

SPARC share price plunged 20% following poor Phase 2 trial outcomes for SCD-044. The stock peaked at ₹186 but fell to ₹156.50 during trading on the BSE.

Sun Pharma shares are in focus after the company halted its Phase II clinical trial for SCD-044. Meanwhile, Zydus ...

While actives like vitamin C, kojic acid, niacinamide, and alpha arbutin do work, they’re a double-edged sword.

Indian equity markets recovered on Thursday after falling for two consecutive sessions. The BSE Sensex rose by 320.70 points ...

The phototherapy lamps market has been witnessing consistent growth due to increasing global health awareness and the rising demand for non-invasive treatment methods. These specialized lamps, used ...

Does Skipping This Skincare Step Make Sunscreen Less Effective? Dermatologists Weigh In originally appeared on Parade.

Too much sun can do more than turn your skin red or brown—it can actually make you sick. About the experts Farah Moustafa, MD ...

Nail Growth Support: Healthy nails grow faster when the underlying tissue is free of infection and irritation. Using Tea Tree ...

Maruti Suzuki share price gained nearly 1 per cent in Wednesday's trading session (June 4) after the carmaker announced the ...

Red light therapy can help improve skin texture, wound healing, and pain. The key to success is using it consistently and ...